Literature DB >> 25926560

Contraception and cardiovascular disease.

Jolien W Roos-Hesselink1, Jerome Cornette2, Karen Sliwa3, Petronella G Pieper4, Gruschen R Veldtman5, Mark R Johnson6.   

Abstract

Contraceptive counselling should begin early in females with heart disease, preferably directly after the start of menstruation. In coming to a decision about the method of contraception, the following issues should be considered: (i) the risk of pregnancy for the mother and the consequences of an unplanned pregnancy; (ii) the risks of the contraceptive method; (iii) failure rates; (iv) the non-contraceptive benefits; (v) the availability; (vi) the individual's preferences; (vii) protection against infection; and (viii) costs. In some women with heart disease, the issues may be complex and require the input of both a cardiologist and an obstetrician (or other feto-maternal expert) to identify the optimal approach. No studies have been performed in women with heart disease to investigate the relative risks and benefits of different contraceptive methods. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiovascular; Contraception; Heart disease; Pregnancy

Mesh:

Substances:

Year:  2015        PMID: 25926560     DOI: 10.1093/eurheartj/ehv141

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  13 in total

1.  The family planning "know-do" gap among married women of reproductive age in urban Pakistan.

Authors:  S Yameen; S Nausheen; I Hussain; K Hackett; A Rizvi; U Ansari; Z S Lassi; D Canning; I Shah; S B Soofi
Journal:  Public Health Action       Date:  2021-09-21

2.  Safety of contraceptive use among women with congenital heart disease: A systematic review.

Authors:  Ginnie Abarbanell; Naomi K Tepper; Sherry L Farr
Journal:  Congenit Heart Dis       Date:  2019-01-25       Impact factor: 2.007

Review 3.  Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation.

Authors:  Anjli Maroo; Johnny Chahine
Journal:  Curr Heart Fail Rep       Date:  2018-06

4.  Engineering tetravalent IgGs with enhanced agglutination potencies for trapping vigorously motile sperm in mucin matrix.

Authors:  Bhawana Shrestha; Alison Schaefer; Elizabeth C Chavez; Alexander J Kopp; Timothy M Jacobs; Thomas R Moench; Samuel K Lai
Journal:  Acta Biomater       Date:  2020-09-13       Impact factor: 8.947

5.  Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraception.

Authors:  Bhawana Shrestha; Alison Schaefer; Yong Zhu; Jamal Saada; Timothy M Jacobs; Elizabeth C Chavez; Stuart S Olmsted; Carlos A Cruz-Teran; Gabriela Baldeon Vaca; Kathleen Vincent; Thomas R Moench; Samuel K Lai
Journal:  Sci Transl Med       Date:  2021-08-11       Impact factor: 17.956

Review 6.  The Pan-African Society of Cardiology position paper on reproductive healthcare for women with rheumatic heart disease.

Authors:  Ana Olga Mocumbi; Keila K Jamal; Amam Mbakwem; Maylene Shung-King; Karen Sliwa
Journal:  Cardiovasc J Afr       Date:  2018-09-18       Impact factor: 0.802

Review 7.  Peripartum Cardiomyopathy: an Update.

Authors:  Feriel Azibani; Karen Sliwa
Journal:  Curr Heart Fail Rep       Date:  2018-10

Review 8.  Valvular Heart Disease in Pregnancy.

Authors:  Jennifer Lewey; Lauren Andrade; Lisa D Levine
Journal:  Cardiol Clin       Date:  2020-11-02       Impact factor: 2.213

Review 9.  Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

Authors:  Cinzia Perrino; Péter Ferdinandy; Hans E Bøtker; Bianca J J M Brundel; Peter Collins; Sean M Davidson; Hester M den Ruijter; Felix B Engel; Eva Gerdts; Henrique Girao; Mariann Gyöngyösi; Derek J Hausenloy; Sandrine Lecour; Rosalinda Madonna; Michael Marber; Elizabeth Murphy; Maurizio Pesce; Vera Regitz-Zagrosek; Joost P G Sluijter; Sabine Steffens; Can Gollmann-Tepeköylü; Linda W Van Laake; Sophie Van Linthout; Rainer Schulz; Kirsti Ytrehus
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

10.  Rheumatic heart disease in pregnancy: a report of 2 cases.

Authors:  Asaph Ziruma; Munyaradzi Innocent Nyakanda; Annie Fungai Muyotcha; Fungisai Nyarai Hove; Mugove Gerald Madziyire
Journal:  Pan Afr Med J       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.